Literature DB >> 15046787

Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity.

Sue Choi1, Masaki Nishikawa, Akiyoshi Sakoda, Yasuyuki Sakai.   

Abstract

A simple double-layered coculture system using Caco-2 cell and Hep G2 cell, which mimic metabolic processes occurring in humans such as absorption through the intestine and cytochrome P450 1A1/2 involving biotransformation in both the intestine and liver cells, was used to investigate the toxicity of model chemical, benzo[a]pyrene (B[a]P). It was found that both Caco-2 and Hep G2 cells can metabolize B[a]P to toxic metabolites including B[a]P-7,8-hydrodiol (7,8-diol), an immediate precursor to the highly-reactive ultimate toxicant of B[a]P, B[a]P-7,8-hydrodiol-9,10-epoxide (BPDE), possibly mediated by cytochrome P450 1A1/2 activity. However, in a double-layered coculture system, no significant reduction of Hep G2 cell viability was found, although an approximately 50% reduction in viability was observed in pure Hep G2 cells. HPLC analysis showed that Caco-2 cells transfer B[a]P and its toxic metabolites back to the apical side, thus decreasing the concentrations of toxic metabolites including B[a]P-7,8-hydrodiol (7,8-diol) in cocultured Hep G2 cells. These results appear to be correlated with in vivo data on the effects of orally administered B[a]P, that is, low (10%) bioavailability in the rats and almost no acute lethal toxicity in rats or mice. As such, the simple double-layered coculture system can provide more accurate information regarding the toxic actions of the hazardous chemicals in humans than a pure culture system, as it also gives the final toxicity as a result of many complicated phenomena such as selective permeation in the intestine and biotransformation in the intestine and liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046787     DOI: 10.1016/j.tiv.2003.09.010

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

Review 2.  Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.

Authors:  Ying I Wang; Carlos Carmona; James J Hickman; Michael L Shuler
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

Review 3.  How multi-organ microdevices can help foster drug development.

Authors:  Mandy B Esch; Alec S T Smith; Jean-Matthieu Prot; Carlota Oleaga; James J Hickman; Michael L Shuler
Journal:  Adv Drug Deliv Rev       Date:  2014-01-09       Impact factor: 15.470

4.  The effects of intestinal LPS exposure on inflammatory responses in a porcine enterohepatic co-culture system.

Authors:  Erzsebet Paszti-Gere; Gabor Matis; Orsolya Farkas; Anna Kulcsar; Orsolya Palocz; Gyorgy Csiko; Zsuzsanna Neogrady; Peter Galfi
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

5.  Dielectrophoretic field-flow fractionation system for detection of aquatic toxicants.

Authors:  Sittisak Pui-ock; Mathuros Ruchirawat; Peter Gascoyne
Journal:  Anal Chem       Date:  2008-09-13       Impact factor: 6.986

6.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury.

Authors:  Mandy B Esch; Gretchen J Mahler; Tracy Stokol; Michael L Shuler
Journal:  Lab Chip       Date:  2014-08-21       Impact factor: 6.799

7.  Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system.

Authors:  Marie Shinohara; Hiroshi Arakawa; Yuuichi Oda; Nobuaki Shiraki; Shinji Sugiura; Takumi Nishiuchi; Taku Satoh; Keita Iino; Sylvia Leo; Yusuke Kato; Karin Araya; Takumi Kawanishi; Tomoki Nakatsuji; Manami Mitsuta; Kosuke Inamura; Tomomi Goto; Kenta Shinha; Wataru Nihei; Kikuo Komori; Masaki Nishikawa; Shoen Kume; Yukio Kato; Toshiyuki Kanamori; Yasuyuki Sakai; Hiroshi Kimura
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.